Sequence Towards Recovery in Depression - STRIDE

niversity of Helsinki - Erkki Isometsä0 个研究点开始时间: 2014年5月30日最近更新: 2014年8月11日

适应症

试验速览

暂无简介。

•Major depressive disorder with current major de-pressive episode according to a SCID-I/P interview
•Montgomery-Åsberg depression rating score 15-30
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•-Borderline, schizoid or schizotypal personality disorder
•-Bipolar disorder
•-Any psychotic disorder
•-Primary diagnosis is anxiety disorder: 300.01, 300.21, 300.22, 300.29, 300.23, 300.3, 309.81, 308.3, 300.02, 293.89, 300.00
•-Significant current suicidal ideation, or history of a suicide attempt
•-Lifetime substance dependence; Last-year substance abuse; Last month over 24/16 standard doses of alcohol/week; Lifetime use of illicit substances >x5; any illicit substance use in last month; other clinical reason to suspect substance use disorder
•-Depressive disorder due to medical condition or chemical substance
•-Antidepressant medication use in last 4 months
•-Severe, unstable somatic illness
•-Use of; antipsychotics, mood stabilizers, systemic corticosteroids, ß-blockers or daytime benzodiazepines (a small dose of =10mg zolpidem once daily is permissible)

发起方

niversity of Helsinki - Erkki Isometsä